| Literature DB >> 19663395 |
Carmela Molinaro1, Danny Gauvreau, Gregory Hughes, Stephen Lau, Sophie Lauzon, Rémy Angelaud, Paul D O'Shea, Jacob Janey, Michael Palucki, Scott R Hoerrner, Conrad E Raab, Rick R Sidler, Michel Belley, Yongxin Han.
Abstract
A practical large-scale chromatography-free synthesis of EP4 antagonist MF-310, a potential new treatment for chronic inflammation, is presented. The synthetic route provided MF-310 as its sodium salt in 10 steps and 17% overall yield from commercially available pyridine dicarboxylate 7. The key features of this sequence include a unique regioselective reduction of succinimide 2 controlled by the electronic properties of a remote pyridine ring, preparation of cyclopropane carboxylic acid 3 via a Corey-Chaykovsky cyclopropanation, and a short synthesis of sulfonamide 5.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19663395 DOI: 10.1021/jo901267x
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354